Trials / Completed
CompletedNCT02686398
Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis
Immunogenicity of a Trivalent Influenza Vaccine in Patients With Chronic Kidney Disease Undergoing Hemodialysis: MF59-adjuvanted Versus Non-adjuvanted Vaccines
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 174 (actual)
- Sponsor
- Korea University Guro Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
During the 2013-2014 influenza season, CKD patients undergoing HD participated in the study. The patients were randomized into two groups (MF59-adjuvanted vaccine group or non-adjuvanted vaccine group) and were immunized with the respective vaccine. Sera were collected prior to vaccination and at 1and 6 months post vaccination. Levels of hemagglutination inhibition (HI) antibodies were measured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Fluad | |
| BIOLOGICAL | Agrippal |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2016-02-19
- Last updated
- 2016-02-19
Source: ClinicalTrials.gov record NCT02686398. Inclusion in this directory is not an endorsement.